Table 3 Outcomes of patients with septic shock in the entire study cohort and propensity-matched sample
From: Activated protein C in septic shock: a propensity-matched analysis
Overall, n= 563 n (%) | Treated matched, n= 108 n (%) | Untreated matched, n= 108 n (%) | P a | |
|---|---|---|---|---|
Main outcomes | ||||
Length of stay, median days, (IQR)b | 22 (12, 39) | 19.5 (11, 33) | 27 (12, 45) | 0.11 |
Hospital mortality | 266 (47.2) | 38 (35.2) | 57 (53.8) | 0.005 |
Intensive care unit outcomes | ||||
Mortality | 226 (40.1) | 36 (33.3) | 47 (43.5) | 0.09 |
Length of stay, median days, (IQR) | 9.3 (4.0, 21.3) | 11 (6, 22) | 11.3 (4.5, 28) | 0.90 |
Days on ventilator, median, (IQR) | 8.8 (3.7, 22.6) | 9 (6, 22) | 8.7 (4.3, 24) | 0.80 |
Days on vasopressors, median, (IQR) | 2 (1, 3) | 2 (1, 4) | 2 (1, 3) | 0.90 |
Complications | ||||
Gastrointestinal bleeding | 9 (1.6) | 3 (2.8) | 0 (0.0) | 1.00 |
Intracranial bleeding | 1 (0.2) | 0 (0) | 0 (0) | 1.00 |
Minor transfusion | 216 (38.4) | 38 (35.2) | 45 (41.7) | 0.27 |
Major transfusion | 45 (8.5) | 4 (3.7) | 10 (9.3) | 0.09 |
Any transfusion(minor and/or major) | 243 (43.2) | 41 (38.0) | 50 (46.3) | 0.16 |